June 2026Datroway recommended for approval in the EU by CHMP as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy Recommendation ...
EMA committee recommends approval of AstraZeneca & Daiichi Sankyo’s Datroway for 1st-line treatment for patients with metastatic TNBC who are not candidates for immunotherapy: C ...
16don MSN
SpaceX Just Went Public at $2.1 Trillion. Here's Where History Says the Stock Will Be in 1 Year.
Elon Musk's company closed its first trading session almost 20% above its offering price.
Comcast (CMCSA) stock is rated a Buy at $22, with a deep value profile but faces intense broadband competition and revenue ...
One company posts a sharp rebound in revenue, while the other races ahead with triple-digit growth, but both face steep risks and valuation hurdles in 2026.
Early data suggest KLN-1010, now acquired by Eli Lilly, could be more tolerable but less efficacious that AstraZeneca’s ESOT-01.
It’s easy to see the appeal of Graves in the modern NBA, given how much he helps you win the possession battle. He gets ...
CAPRICORN (Dec. 22-Jan. 19): You can turn a negative into a positive with an energy push to reconstruct how you use your skills to make your life manageable. Less time wasted on someone who is all ...
TDG Gold Corp. ("TDG" or the "Company") (TSXV: TDG | OTCQX: TDGGF) is pleased to provide an update on the ongoing metallurgical test work ...
Nifty50 and BSE Sensex ended in green after a negative start to the day on Tuesday. Stock markets are likely to be ran ...
Perpetua Resources is transitioning from a typical gold developer to a strategic U.S. gold/antimony project. Check out why PPTA stock is a buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results